摘要
胰腺导管内乳头状黏液性肿瘤(IPMN)是一种具有恶性潜能的胰腺囊性病变,其管理依赖于准确的诊断、风险分层和监测。内镜技术,尤其是超声内镜(EUS)和内镜逆行胰胆管造影(ERCP),在IPMN的诊断、风险评估和治疗决策中起到重要作用。然而,其应用仍面临技术限制、操作依赖性、成本效益考量及长期监测策略的争议等挑战。本文旨在综述消化内镜技术在IPMN诊疗中的应用现状与最新进展,并探讨其未来在实现个体化精准管理方面的优化方向。
Pancreatic intraductal papillary mucinous neoplasm(IPMN)is a pancreatic cystic lesion with malignant potential,the management of which relies on accurate diagnosis,risk stratification,and surveillance.Endoscopic techniques,particularly endoscopic ultrasound(EUS)and endoscopic retrograde cholangiopancreatography(ERCP),play crucial roles in the diagnosis,risk assessment,and therapeutic decision-making for IPMN.However,their application still faces challenges including technical limitations,operator dependence,cost-effectiveness considerations,and controversies regarding long-term surveillance strategies.This article comprehensively reviewed the current applications and recent advancements in gastrointestinal endoscopy for managing IPMN,and discussed future directions for refining personalized,precision-based treatment approaches.
作者
徐琬倩
周春华
邹多武
XU Wanqian;ZHOU Chunhua;ZOU Duowu(Department of Gastroenterology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)
出处
《外科理论与实践》
2025年第5期369-377,共9页
Journal of Surgery Concepts & Practice
基金
国家自然科学基金(82270667)。
关键词
胰腺导管内乳头状黏液性肿瘤
超声内镜
内镜逆行胰胆管造影
Pancreatic intraductal papillary mucinous neoplasm(IPMN)
Endoscopic ultrasound(EUS)
Endoscopic retrograde cholangiopancreatography(ERCP)
